Advisor Group Holdings, Inc. Windtree Therapeutics Inc Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.16 - $0.2 $1,633 - $2,041	10,209 Added 28.24%	46,357 $7,000
Q3 2022 Nov 14, 2022	BUY	$0.3 - $0.7 $9,742 - $22,732	32,475 Added 884.15%	36,148 $11,000
Q2 2022 Aug 10, 2022	BUY	$0.38 - $1.14 $240 - $721	633 Added 20.82%	3,673 $1,000
Q1 2022 May 04, 2022	BUY	$0.94 - $1.6 $400 - $681	426 Added 16.3%	3,040 $5,000
Q3 2021 Nov 05, 2021	SELL	$1.66 - $2.27 $6,553 - $8,961	-3,948 Reduced 60.16%	2,614 $5,000

Q2 2021 Aug 02, 2021	BUY	$1.68 - $2.79 $2,750 - $4,567	1,637 Added 33.24%	6,562 $15,000
Q1 2021 May 13, 2021	BUY	$2.14 - $6.18 $10,539 - $30,436	4,925 New	4,925 $12,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $113M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.